Table 2.
Revised articles about MRI, split for peripheral, or axial subset of disease.
| MRI and peripheral disease | |||
|---|---|---|---|
| First Author | Reference | Title | Description |
| Glinatsi et al. (54) | J Rheumatol. (2015) | Validation of the OMERACT psoriatic arthritis magnetic resonance imaging score (PsAMRIS) for the Hand and foot in a randomized placebo-controlled trial | PsAMRIS showed overall good intrareader agreement in the hand and foot, and inflammatory feature scores were responsive to change, suggesting that PsAMRIS may be a valid tool for MRI assessment of hands and feet in PsA clinical trials. |
| Mathew et al. (56) | J Rheumatol. (2019) | The OMERACT MRI in enthesitis initiative: definitions of key pathologies, suggested MRI sequences, and a novel heel enthesitis scoring system | Heel Enthesitis Scoring System (HEMRIS) showed to be reliable among trained readers and promising for clinical trials. |
| Feydy et al. (58) | Ann Rheum Dis. (2012) | Comparative study of MRI and power Doppler ultrasonography of the heel in patients with spondyloarthritis with and without heel pain and in controls | Heel MRI and PDUS frequently show inflammatory lesions in SpA, particularly in painful heels. However, they were also often abnormal in controls. These results suggest that heel MRI and PDUS cannot be used for the diagnosis of SpA. However, PDUS and MRI may be useful for the depiction and assessment of enthesis inflammatory lesions in patients with SpA with heel pain. |
| Narvàez et al. (59) | Semin Arthritis Rheum. (2012) | Can magnetic resonance imaging of the hand and wrist differentiate between rheumatoid arthritis and psoriatic arthritis in the early stages of the disease? | Significant differences were observed in the MRI findings of the hand and wrist that can help to distinguish between RA and PsA in the early stages of disease. This imaging method was suggested to be able to help in the differential diagnostic process in selected patients in whom diagnosis cannot be unequivocally established after conventional clinical, biochemical, and radiographic examinations. |
| Helliwell et al. (41) | J Rheumatol. (2019) | Comparing psoriatic arthritis low-field magnetic resonance imaging, ultrasound and clinical outcomes: data from the TICOPA trial | See US table |
| Mathew et al. (66) | Clin Rheumatol. (2018) | Magnetic resonance imaging (MRI) of feet demonstrates subclinical inflammatory joint disease in cutaneous psoriasis patients without clinical arthritis | Evidence of inflammation was present in 33.9 and 50% patients in the PsO and PsA groups, respectively. Early arthritis for psoriatic patients screening questionnaire (EARP) score of ≥ 3 was significantly associated with imaging features of inflammation in PsO group (p = 0.044). The study suggested a high proportion of subclinical inflammation in small joints of foot in PsO patients. |
| Faustini (67) | Ann Rheum Dis. (2016) | Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: a cross-sectional and longitudinal analysis. | Prevalence of subclinical inflammatory lesions is high in patients with cutaneous psoriasis. Arthralgia in conjunction with MRI synovitis constitutes a high-risk constellation for the development of PsA. |
| MRI and axial involvement in PsA | |||
| Maksymowych et al. (69) | Ann Rheum Dis. (2019) | MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group | Multi-reader validation demonstrated substantial reliability for the most frequently detected lesions and comparable reliability between active and structural lesions |
| Monaldo-Ficco et al. (70) | Musculoskelet Dis. (2017) | Magnetic Resonance Imaging in Psoriatic Arthritis: A Descriptive Study of Indications, Features and Effect on Treatment Change. | Magnetic resonance imaging is useful in evaluating patients with active PsA, particularly when suspecting inflammation and radiographic findings are unhelpful. In some cases, it can be used as an adjunct to clinical examination in determining treatment change. |
| Poggenborg et al. (71) | Rheumatol Oxf Engl. (2015) | Head-to-toe whole-body MRI in psoriatic arthritis, axial spondyloarthritis and healthy subjects: first steps toward global inflammation and damage scores of peripheral and axial joints | Whole-body MRI (WBMRI) allows simultaneous assessment of peripheral and axial joints in PsA and SpA, and the distribution of inflammatory and structural lesions and global scores can be determined. The study strongly encourages further development and longitudinal testing of WBMRI techniques and assessment methods in PsA and SpA |